- Home
- PROK vs GMM Comparison
PROK vs GMM Comparison
Compare PROK & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- GMM
- Stock Information
- Founded
- PROK 2015
- GMM 2017
- Country
- PROK United States
- GMM China
- Employees
- PROK N/A
- GMM N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- GMM
- Sector
- PROK Health Care
- GMM
- Exchange
- PROK Nasdaq
- GMM Nasdaq
- Market Cap
- PROK 85.5M
- GMM 70.8M
- IPO Year
- PROK N/A
- GMM 2023
- Fundamental
- Price
- PROK $4.74
- GMM $2.81
- Analyst Decision
- PROK Buy
- GMM
- Analyst Count
- PROK 4
- GMM 0
- Target Price
- PROK $5.33
- GMM N/A
- AVG Volume (30 Days)
- PROK 33.1M
- GMM 10.5K
- Earning Date
- PROK 08-08-2025
- GMM 07-18-2025
- Dividend Yield
- PROK N/A
- GMM N/A
- EPS Growth
- PROK N/A
- GMM 62.17
- EPS
- PROK N/A
- GMM 6.37
- Revenue
- PROK $306,000.00
- GMM $41,360,953.00
- Revenue This Year
- PROK $54.34
- GMM N/A
- Revenue Next Year
- PROK N/A
- GMM N/A
- P/E Ratio
- PROK N/A
- GMM $0.43
- Revenue Growth
- PROK N/A
- GMM 53.82
- 52 Week Low
- PROK $0.46
- GMM $1.69
- 52 Week High
- PROK $7.13
- GMM $15.60
- Technical
- Relative Strength Index (RSI)
- PROK 92.14
- GMM 49.62
- Support Level
- PROK $0.54
- GMM $2.64
- Resistance Level
- PROK $7.13
- GMM $2.90
- Average True Range (ATR)
- PROK 0.62
- GMM 0.18
- MACD
- PROK 0.47
- GMM 0.01
- Stochastic Oscillator
- PROK 68.59
- GMM 46.30
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.